Skip to main content

Table 1 Clinical characteristics of study population

From: Perioperative management of thoracic surgery in patients with lymphangioleiomyomatosis

Variables

LAM

Number of patients

12

Sex (male/female)

0/12

Age (years) (mean ± SD)

41.3 ± 10.6

Surgical indication

 

Biopsy for LAM

4 (33.3%)

Pneumothorax

3 (25.0%)

Lung cancer

2 (16.6%)

Empyema

1 (8.3%)

Othersa

2 (16.6%)

Preoperative PaO2 (mmHg)

82.3 ± 12.3

Respiratory function ( n = 9)

 

 VC (L)

3.03 ± 0.40

 %VC (%)

97.9 ± 12.9

 FEV1 (L)

2.18 ± 0.36

 FEV1/FVC (%)

76.01 ± 9.28

 %DLCO (%)

60.8 ± 16.1

Operative time (min)

73.8 ± 39.6

Operative blood loss (ml)

39.8 ± 75.6

  1. FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, LAM lymphangioleiomyomatosis, PaCO2 partial pressure of arterial carbon dioxide, PaO2 partial pressure of arterial oxygen, %DLCO % of the predicted value of diffusing capacity of the lung for carbon monoxide, %VC % of the predicted value of VC, SD standard deviation, VC vital capacity
  2. aOther surgical indications were aspergilloma and benign lung tumor (adenofibroma)